Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides

Abstract

The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or versants thereof that correspond to a novel human secreted stem cell growth factor-like polypeptides. Other aspects of the invention include vectors containing processes for producing novel human secreted stem cell growth factor-like polypeptides, and antibodies specific for such polypeptides.

1 . A method of treating a bone or cartilage disease in a subject in need thereof, said method comprising administering to said subject a composition comprising a therapeutically effective amount of polypeptide comprising an amino acid sequence with at least 95% sequence identity to the amino acid sequence of SEQ ID NO:18 or 27. 
     
     
         2 . The method of  claim 1 , wherein said polypeptide comprises an amino acid sequence with at least 99% sequence identity to the amino acid sequence of SEQ ID NO:18 or 27. 
     
     
         3 . The method of  claim 1 , wherein said polypeptide comprises the amino acid sequence of SEQ ID NO: 18 or 27. 
     
     
         4 . The method of  claim 1 , wherein said method is for treating a bone disease. 
     
     
         5 . The method of  claim 4 , wherein said bone disease is a bone degenerative disease. 
     
     
         6 . The method of  claim 5 , wherein said bone degenerative disease is osteoporosis. 
     
     
         7 . The method of  claim 4 , wherein said bone disease is osteoarthritis. 
     
     
         8 . The method of  claim 1 , wherein said method is for treating periodontal disease. 
     
     
         9 . A method of stimulating cell proliferation comprising contacting a bone cell, a bone-forming cell or a cartilage cell with an amount of a polypeptide effective to promote proliferation of said cell, wherein said polypeptide comprises a cell proliferative amino acid sequence with at least 95% sequence identity to the amino acid sequence of SEQ ID NO:18 or 27. 
     
     
         10 . The method of  claim 9 , wherein said polypeptide comprises an amino acid sequence with at least 99% sequence identity to the amino acid sequence of SEQ ID NO:18 or 27. 
     
     
         11 . The method of  claim 9 , wherein said polypeptide comprises the amino acid sequence of SEQ ID NO: 18 or 27. 
     
     
         12 . The method of  claim 9 , wherein said method comprises contacting said cell in vitro. 
     
     
         13 . The method of  claim 9 , wherein said method comprises contacting said cell in vivo.